Explore the detailed record of transactions filed by 박철세, Independent Director. Officer active across 2 companies, notably 바이오노트. Aggregated, 17,943 filings have been published. Activity tracked since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Park Cheol-se is an Independent Director at BioNote. In this role, he provides an outside perspective and strategic advice to the board of directors, contributing to the company's governance and decision-making.